Innovative Biologics' Grant

Innovative Biologics raised a round of funding on July 22, 2008. Investors include National Institutes of Health.

IBI has recently demonstrated that treatment of Bacillus anthracis infected mice with a combination of the antibiotic ciprofloxacin and partially purified antibodies against anthrax protective antigen…

Articles about Innovative Biologics' Grant: